InvestorsHub Logo
Followers 30
Posts 2500
Boards Moderated 0
Alias Born 07/28/2005

Re: biopharm post# 309008

Friday, 08/18/2017 12:09:03 AM

Friday, August 18, 2017 12:09:03 AM

Post# of 345890
Bio, picks for a Board candidate might be preceded by an assessment of what attributes are needed to better direct PPHM going forward. This message board has emphasized how BOD decision making that allows over compensation is a problem and the Delaware Chancery put an exclamation mark on that.

Beyond that, let's try to be BOD selection objective. Here are attributes that come to mind:
- background in phama deal making.
- business experience with managing customer development for a mabufacturing facility.
- familiarity with the drug candidate development and approval process
- financing experience and contacts
- legal experience with developing and protecting intellectal property
- familiarity with trial process, patient care and treatment needs
- business collaboration/partnering development experience
- risk management training
- public communications and relations experience
- research grant application and implementation management
- proprietary tech development and patent application experience
- shareholder relations management experience
- demonstrated knowledge of the Pharma industry structure and operations
- ...

Feel free to add to the list and describe how Board candidates you might suggest fit the needs. I presume the Ronin BOD candidates come with business collaboration experience as a forte and see credentials cover much on the list. The current BODs collectively cover much of the list. No individual is a perfect match. That is why a Board of several Directors with complimentary backgrounds is desirable.

Best wishes and IMO.

KT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News